{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:42:23Z","timestamp":1792716143404,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00259-018-4245-3","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T08:30:07Z","timestamp":1546936207000},"page":"686-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Early 18F-FDOPA PET\/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma"],"prefix":"10.1007","volume":"46","author":[{"given":"Benjamin","family":"Leroy-Freschini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Amodru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Addeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brunaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Bahougne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Goichot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"4245_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","volume":"19","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829\u201337.","journal-title":"World J Gastroenterol"},{"key":"4245_CR2","first-page":"1702","volume-title":"Cancer principles and practice of oncology","author":"JC Yao","year":"2007","unstructured":"Yao JC, Rindi G, Evans DB. Pancreatic endocrine tumors. In: Devita Jr VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1702\u201316.","edition":"8"},{"key":"4245_CR3","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1210\/jcem.85.11.6934","volume":"85","author":"FJ Service","year":"2000","unstructured":"Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab. 2000;85:3973\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"4245_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153\u201371.","journal-title":"Neuroendocrinology"},{"key":"4245_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00259-016-3592-1","volume":"44","author":"A Jodal","year":"2017","unstructured":"Jodal A, Schibli R. Targets and probes for non-invasive imaging of \u03b2-cells. Eur J Nucl Med Mol Imaging. 2017;44:712\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR6","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1530\/ERC-17-0005","volume":"24","author":"DA Pattison","year":"2017","unstructured":"Pattison DA, Hicks RJ. Molecular imaging in the investigation of hypoglycaemic syndromes and their management. Endocr Relat Cancer. 2017;24:R203\u201321.","journal-title":"Endocr Relat Cancer"},{"key":"4245_CR7","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","volume":"45","author":"K Antwi","year":"2018","unstructured":"Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, et al. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. Eur J Nucl Med Mol Imaging. 2018;45:2318\u201327..","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00259-016-3331-7","volume":"43","author":"V Prasad","year":"2016","unstructured":"Prasad V, Sainz-Esteban A, Arsenic R, Pl\u00f6ckinger U, Denecke T, Pape UF, et al. Role of (68)Ga somatostatin receptor PET\/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study. Eur J Nucl Med Mol Imaging. 2016;43:1593\u2013600.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jc.2016-3445","volume":"102","author":"P Nockel","year":"2017","unstructured":"Nockel P, Babic B, Millo C, Herscovitch P, Patel D, Nilubol N, et al. Localization of insulinoma using 68Ga-DOTATATE PET\/CT scan. J Clin Endocrinol Metab. 2017;102:195\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4245_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00259-014-2943-z","volume":"42","author":"A Imperiale","year":"2015","unstructured":"Imperiale A, Sebag F, Vix M, Castinetti F, Kessler L, Moreau F, et al. 18F-FDOPA PET\/CT imaging of insulinoma revisited. Eur J Nucl Med Mol Imaging. 2015;42:409\u201318.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/RLU.0000000000000686","volume":"40","author":"A Imperiale","year":"2015","unstructured":"Imperiale A, Bahougne T, Goichot B, Bachellier P, Ta\u00efeb D, Namer IJ. Dynamic 18F-FDOPA PET findings after carbidopa premedication in 2 adult patients with insulinoma-related hyperinsulinemic hypoglycemia. Clin Nucl Med. 2015;40:682\u20134.","journal-title":"Clin Nucl Med"},{"key":"4245_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2967\/jnumed.116.180588","volume":"58","author":"J Detour","year":"2017","unstructured":"Detour J, Pierre A, Boisson F, Kreutter G, Lavaux T, Namer IJ, et al. Carbidopa effect on 18F-FDOPA uptake in insulinoma: from cell culture to microPET imaging. J Nucl Med. 2017;58:36\u201341.","journal-title":"J Nucl Med"},{"key":"4245_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2967\/jnumed.116.179234","volume":"57","author":"C Deerose","year":"2016","unstructured":"Deerose C, Hindie E, Kebebew E, Goichot B, Pacak K, Taieb D, et al. Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions. J Nucl Med. 2016;57:1949\u201356.","journal-title":"J Nucl Med"},{"key":"4245_CR14","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1200\/JCO.2008.18.8581","volume":"26","author":"S Kauhanen","year":"2008","unstructured":"Kauhanen S, Sepp\u00e4nen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [18F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol. 2008;26:5307\u20138.","journal-title":"J Clin Oncol"},{"key":"4245_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1369\/jhc.5A6770.2006","volume":"54","author":"S Uccella","year":"2006","unstructured":"Uccella S, Cerutti R, Vigetti D, Furlan D, Oldrini R, Carnevali I, et al. Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis. J Histochem Cytochem. 2006;54:863\u201375.","journal-title":"J Histochem Cytochem"},{"key":"4245_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/jc.2009-1357","volume":"95","author":"L Tessonnier","year":"2010","unstructured":"Tessonnier L, Sebag F, Ghander C, De Micco C, Reynaud R, Palazzo FF, et al. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab. 2010;95:303\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"4245_CR17","first-page":"353","volume":"38","author":"TS Nakuz","year":"2018","unstructured":"Nakuz TS, Berger E, El-Rabadi K, Wadsak W, Haug A, Hacker M, et al. Clinical value of 18F-FDOPA PET\/CT with contrast enhancement and without carbidopa premedication in patients with insulinoma. Anticancer Res. 2018;38:353\u20138.","journal-title":"Anticancer Res"},{"key":"4245_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-58380-3_3","volume-title":"Radiology of the pancreas","author":"L Hoe Van","year":"1999","unstructured":"Van Hoe L, Claikens B. The pancreas: normal radiological anatomy and variants. In: Baert AL, Delorme G, Van Hoe L (editors) Radiology of the pancreas. Springer, Berlin, Heidelberg; 1999. p. 19\u201368."},{"key":"4245_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.radonc.2010.07.003","volume":"96","author":"JA Lee","year":"2010","unstructured":"Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol. 2010;96:302\u20137.","journal-title":"Radiother Oncol"},{"key":"4245_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00259-014-2691-0","volume":"41","author":"A Piccardo","year":"2014","unstructured":"Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, et al. Prognostic value of 18F-DOPA PET\/CT at the time of recurrence in patients affected by neuroblastoma. Eur J Nucl Med Mol Imaging. 2014;41:1046\u201356.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR21","unstructured":"Woltering EA, Bergsland EK, Beyer DTL. Neuroendocrine tumors of the stomach. In: Amin MB (editor). AJCC Cancer Staging Manual. Eighth Edition. Chicago: American College of Surgeons; 2017. p. 351\u20139."},{"key":"4245_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00259-016-3354-0","volume":"43","author":"D Ta\u00efeb","year":"2016","unstructured":"Ta\u00efeb D, Imperiale A, Pacak K. 18F-DOPA: the versatile radiopharmaceutical. Eur J Nucl Med Mol Imaging. 2016;43:1187\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MNM.0b013e3283543304","volume":"33","author":"M Soussan","year":"2012","unstructured":"Soussan M, Nataf V, Kerrou K, Grahek D, Pascal O, Talbot JN, et al. Added value of early 18F-FDOPA PET\/CT acquisition time in medullary thyroid cancer. Nucl Med Commun. 2012;33:775\u20139.","journal-title":"Nucl Med Commun"},{"key":"4245_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00259-015-3227-y","volume":"43","author":"A Archier","year":"2016","unstructured":"Archier A, Heimburger C, Guerin C, Morange I, Palazzo FF, Henry JF, et al. 18F-DOPA PET\/CT in the diagnosis and localization of persistent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2016;43:1027\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12149-016-1110-y","volume":"30","author":"M Helali","year":"2016","unstructured":"Helali M, Addeo P, Heimburger C, Detour J, Goichot B, Bachellier P, et al. Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET\/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors. Ann Nucl Med. 2016;30:659\u201368.","journal-title":"Ann Nucl Med"},{"key":"4245_CR26","first-page":"560","volume":"46","author":"MJ Ribeiro","year":"2005","unstructured":"Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med. 2005;46:560\u20136.","journal-title":"J Nucl Med"},{"key":"4245_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2006-1479","volume":"92","author":"S Kauhanen","year":"2007","unstructured":"Kauhanen S, Sepp\u00e4nen M, Minn H, Gullichsen R, Salonen A, Alanen K, et al. Fluorine-18-L-dihydroxyphenylalanine (18F-FDOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab. 2007;92:1237\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"4245_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/jso.23176","volume":"106","author":"HX Zhan","year":"2012","unstructured":"Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G, Zhou L, et al. Activated mTOR\/P70S6K signaling pathway is involved in insulinoma tumorigenesis. J Surg Oncol. 2012;106:972\u201380.","journal-title":"J Surg Oncol"},{"key":"4245_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/1535-7163.MCT-17-0325","volume":"17","author":"J Bollard","year":"2018","unstructured":"Bollard J, Patte C, Massoma P, Goddard I, Gadot N, Benslama N, et al. Combinatorial treatment with mTOR inhibitors and streptozotocin leads to synergistic in vitro and in vivo antitumor effects in insulinoma cells. Mol Cancer Ther. 2018;17:60\u201372.","journal-title":"Mol Cancer Ther"},{"key":"4245_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00259-017-3833-y","volume":"45","author":"V Amodru","year":"2018","unstructured":"Amodru V, Guerin C, Delcourt S, Romanet P, Loundou A, Viana B, et al. Quantitative 18F-FDOPA PET\/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype. Eur J Nucl Med Mol Imaging. 2018;45:278\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR31","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00259-011-1862-5","volume":"38","author":"HB Fiebrich","year":"2011","unstructured":"Fiebrich HB, de Jong JR, Kema IP, Koopmans KP, Sluiter W, Dierckx RA, et al. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumor. Eur J Nucl Med Mol Imaging. 2011;38:1854\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4245_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00261-014-0219-5","volume":"40","author":"P Sharma","year":"2015","unstructured":"Sharma P, Arora S, Dhull VS, Naswa N, Kumar R, Ammini AC, et al. Evaluation of (68)Ga-DOTANOC PET\/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging. 2015;40:299\u2013309.","journal-title":"Abdom Imaging"},{"key":"4245_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2967\/jnumed.115.167445","volume":"57","author":"Y Luo","year":"2016","unstructured":"Luo Y, Pan Q, Yao S, Yu M, Wu W, Xue H, et al. Glucagon-like Peptide-1 receptor PET\/CT with 68Ga-NOTA-exendin-4 for detecting localized insulinoma: a prospective cohort study. J Nucl Med. 2016;57:715\u201320.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4245-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T23:32:41Z","timestamp":1606001561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4245"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4245-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}